Literature DB >> 9397304

Cardiac involvement in Behçet's disease.

S Morelli1, C Perrone, L Ferrante, A Sgreccia, R Priori, P Voci, M Accorinti, P Pivetti-Pezzi, G Valesini.   

Abstract

To assess the prevalence and the extent of cardiac involvement in patients with Behçet's disease and to investigate the possible causes that may predispose to this involvement, 30 patients affected by Behçet's disease and 30 normal control subjects were submitted to M-mode, two-dimensional, and Doppler echocardiographic evaluation. Moreover, antinuclear and anticardiolipin autoantibodies were determined in the sera of both patients and control subjects. Finally, HLA-B51 positivity was assessed in the patients and in a historical control group. Mitral valve prolapse was observed in 50% and proximal aorta dilatation in 30% of the patients. There was a significant difference in the rate of these abnormalities in comparison with the control group. Left ventricular function parameters were similar between the two groups. The positivity rate of antinuclear and anticardiolipin autoantibodies was very low (7%), without differences between the groups. HLA-B51 was detected in 82.7% of the patients versus 21.7% in the control group (p < 0.00001). In conclusion, this study demonstrates a high rate of cardiac abnormalities in patients with Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9397304     DOI: 10.1159/000177401

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  6 in total

Review 1.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  Behcet's disease: from East to West.

Authors:  Fereydoun Davatchi; Farhad Shahram; Cheyda Chams-Davatchi; Hormoz Shams; Abdolhadi Nadji; Massoomeh Akhlaghi; Tahereh Faezi; Zahra Ghodsi; Alireza Faridar; Farima Ashofteh; Bahar Sadeghi Abdollahi
Journal:  Clin Rheumatol       Date:  2010-03-31       Impact factor: 2.980

Review 3.  Cardiovascular involvement in Behçet's disease.

Authors:  Yusuf Sezen; Hakan Buyukhatipoglu; Hakan Buyukatipoglu; Zekeriya Kucukdurmaz; Ramazan Geyik
Journal:  Clin Rheumatol       Date:  2009-10-16       Impact factor: 2.980

Review 4.  Cardiac Function and Diastolic Dysfunction in Behcet's Disease: A Systematic Review and Meta-Analysis.

Authors:  Fawad Aslam; Salman J Bandeali; Cynthia Crowson; Mahboob Alam
Journal:  Int J Rheumatol       Date:  2016-05-10

5.  Superior vena cava thrombosis and dilated cardiomyopathy as initial presentations of Behcet's disease.

Authors:  Ahmed M Elzanaty; Mohammed T Awad; Ashu Acharaya; Ebrahim Sabbagh; Eman Elsheikh; Moshrik AbdAlamir
Journal:  Thromb J       Date:  2020-07-06

6.  Severe Chest Pain in a Young Patient with Behçet's Disease: A Rare Manifestation.

Authors:  Steen Reed; Michael McGee; Shanathan Sritharan
Journal:  Case Rep Cardiol       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.